Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer

被引:226
作者
Hwang, RF
Krishnamurthy, S
Hunt, KK
Mirza, N
Ames, FC
Feig, B
Kuerer, HM
Singletary, SE
Babiera, G
Meric, F
Akins, JS
Neely, J
Ross, MI
机构
[1] UT MD Anderson Canc Ctr, Surg Breast Sect, Houston, TX 77030 USA
[2] UT MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA
[3] UT MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA
关键词
sentinel lymph node; predictive factors; axillary dissection; breast cancer;
D O I
10.1245/ASO.2003.05.020
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: It is unclear which breast cancer patients with positive sentinel lymph nodes (SLNs) require a completion axillary lymph node dissection. Our aim was to determine factors that,predict involvement of nonsentinel axillary nodes (NSLNs) in patients with positive SLNs. Methods: We reviewed the records of all patients with invasive breast cancer who underwent SLN biopsy at our institution between 1993 and August 2001. Multivariate analysis was used to identify clinicopathologic features in SLN-positive patients that predict involvement of NSLNs. Results: A total of 131 patients had a positive SLN and underwent completion axillary lymph node dissection. Multivariate analysis revealed that primary tumor >2 cm (P = .009), SLN metastasis >2 mm (P = .024), and lymphovascular invasion (P = .028) were independent predictors of positive NSLNs. The number of SLNs harvested was a significant negative predictor (P = .04). In our model, based on the presence of these factors, the positive predictive value was 100% for a score of 4. Conclusions: The likelihood of positive NSLNs correlates with primary tumor size, size of the largest SLN metastasis, and presence of lymphovascular invasion. A scoring system incorporating these factors may help determine which patients would benefit from additional axillary surgery.
引用
收藏
页码:248 / 254
页数:7
相关论文
共 28 条
  • [21] Sentinel lymph node biopsy with metastasis: Can axillary dissection be avoided in some patients with breast cancer?
    Reynolds, C
    Mick, R
    Donohue, JH
    Grant, CS
    Farley, DR
    Callans, LS
    Orel, SG
    Keeney, GL
    Lawton, TJ
    Czerniecki, BJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (06) : 1720 - 1726
  • [22] Turner RR, 2000, CANCER-AM CANCER SOC, V89, P574, DOI 10.1002/1097-0142(20000801)89:3<574::AID-CNCR12>3.0.CO
  • [23] 2-Y
  • [24] Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes
    Veronesi, U
    Paganelli, G
    Galimberti, V
    Viale, G
    Zurrida, S
    Bedoni, M
    Costa, A
    deCicco, C
    Geraghty, JG
    Luini, A
    Sacchini, V
    Veronesi, P
    [J]. LANCET, 1997, 349 (9069) : 1864 - 1867
  • [25] Lymphovascular invasion enhances the prediction of non-sentinel node metastases in breast cancer patients with positive sentinel nodes
    Weiser, MR
    Montgomery, LL
    Tan, LK
    Susnik, B
    Leung, DYH
    Borgen, PI
    Cody, HS
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2001, 8 (02) : 145 - 149
  • [26] Predicting the status of the nonsentinel axillary nodes a -: Multicenter study
    Wong, SL
    Edwards, MJ
    Chao, C
    Tuttle, TM
    Noyes, RD
    Woo, C
    Cerrito, PB
    McMasters, KM
    [J]. ARCHIVES OF SURGERY, 2001, 136 (05) : 563 - 567
  • [27] Recommendations for sentinel lymph node processing in breast cancer
    Yared, MA
    Middleton, LP
    Smith, TL
    Kim, HW
    Ross, MI
    Hunt, KK
    Sahin, AA
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2002, 26 (03) : 377 - 382
  • [28] 2001, J NATL CANC I MONOGR, V30, P5